Drug Shortage Report for CISPLATIN INJECTION, BP
| Report ID | 3275 |
| Drug Identification Number | 02355183 |
| Brand name | CISPLATIN INJECTION, BP |
| Common or Proper name | CISPLATIN |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CISPLATIN |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 100 ML VIAL OF 100 MG | FLACON DE 100 ML DE 100 MG |
| ATC code | L01XA |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-03-06 |
| Actual start date | 2017-03-06 |
| Estimated end date | 2017-04-12 |
| Actual end date | 2017-03-30 |
| Shortage status | Resolved |
| Updated date | 2017-04-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2017-04-06 | English | Compare |
| v4 | 2017-03-17 | French | Compare |
| v3 | 2017-03-17 | English | Compare |
| v2 | 2017-03-17 | French | Compare |
| v1 | 2017-03-17 | English | Compare |
Showing 1 to 5 of 5